Athira Pharma
$19.349876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$19.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.76 (-3.78%) Today
$0.00 (0.00%) As of 8:00 PM EDT after-hours
Why Robinhood?
You can buy or sell Athira Pharma and other stocks, options, and ETFs commission-free!
About ATHA
Athira Pharma, Inc. Common Stock, also called Athira Pharma, is a clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration. Read More The company was founded by Leen Kawas and Joseph Harding in 2011 and is headquartered in Seattle, WA. The listed name for ATHA is Athira Pharma, Inc. Common Stock.
CEO
Employees
15
Headquarters
Seattle, Washington
Founded
2011
Market Cap
596.05M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
428.00K
High Today
$20.04
Low Today
$19.28
Open Price
$20.00
Volume
73.16K
52 Week High
$22.14
52 Week Low
$15.79